Institutional investors purchased a net $643.4 thousand shares of NLNK during the quarter ended June 2015. This may signal that the smart money is gaining interest in this company as the 61.95% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIRST EAGLE INVESTMENT MANAGEMEN... Bought 1.3 Million shares of NewLink Genetics Corp